PubRank

Jeremy E Turnbull

Author PubWeight™ 46.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 2004 1.83
2 Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies. J Am Chem Soc 2009 1.72
3 Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 2002 1.41
4 A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. J Biol Chem 2006 1.37
5 Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 2005 1.36
6 Fabrication of carbohydrate microarrays on gold surfaces: direct attachment of nonderivatized oligosaccharides to hydrazide-modified self-assembled monolayers. Anal Chem 2006 1.24
7 Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. Glycobiology 2002 1.18
8 Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation. J Biol Chem 2008 1.14
9 Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J Cell Biol 2003 1.11
10 Extracellular regulation of developmental cell signaling by XtSulf1. Dev Biol 2008 1.10
11 Specific heparan sulfate structures involved in retinal axon targeting. Development 2002 1.09
12 Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2005 1.09
13 A versatile gold surface approach for fabrication and interrogation of glycoarrays. Chembiochem 2008 1.08
14 Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex. J Biol Chem 2002 1.07
15 Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling. J Biol Chem 2009 1.06
16 Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities. J Biol Chem 2009 1.05
17 The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 2010 1.03
18 Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease. Chemistry 2013 1.02
19 Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1. J Biol Chem 2009 1.01
20 Software tool for the structural determination of glycosaminoglycans by mass spectrometry. Anal Chem 2008 0.95
21 Generating heparan sulfate saccharide libraries for glycomics applications. Nat Protoc 2010 0.95
22 Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection. Nat Protoc 2010 0.94
23 Labelling heparan sulphate saccharides with chromophore, fluorescence and mass tags for HPLC and MS separations. Methods Mol Biol 2009 0.93
24 Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships. Org Biomol Chem 2010 0.92
25 Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. Glycobiology 2007 0.91
26 Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry. Glycobiology 2007 0.90
27 Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases. J Med Chem 2006 0.90
28 Saccharide microarrays for high-throughput interrogation of glycan-protein binding interactions. Methods Mol Biol 2009 0.89
29 Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening. J Med Chem 2004 0.89
30 Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities. J Med Chem 2008 0.87
31 The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids. Thromb Haemost 2009 0.85
32 The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation. Connect Tissue Res 2008 0.83
33 Heparan sulfate in lung morphogenesis: The elephant in the room. Birth Defects Res C Embryo Today 2010 0.82
34 Array-based functional screening of heparin glycans. Chem Biol 2012 0.82
35 Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation? BMC Dev Biol 2011 0.82
36 Heparan sulfotransferases Hs6st1 and Hs2st keep Erk in check for mouse corpus callosum development. J Neurosci 2014 0.81
37 Attachment of glycosaminoglycan oligosaccharides to thiol-derivatised gold surfaces. Chem Commun (Camb) 2004 0.81
38 Proteoglycans make the grade-ient. Mol Cell 2004 0.80
39 An expression system for screening of proteins for glycan and protein interactions. Anal Biochem 2011 0.80
40 Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation. J Neurosci 2012 0.80
41 The geometric control of E14 and R1 mouse embryonic stem cell pluripotency by plasma polymer surface chemical gradients. Biomaterials 2008 0.79
42 Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding. Org Biomol Chem 2015 0.78
43 Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solution. Biochemistry 2009 0.78
44 Engineered bio-active polysaccharides from heparin. Macromol Biosci 2006 0.77
45 Single-entity heparan sulfate glycomimetic clusters for therapeutic applications. Angew Chem Int Ed Engl 2015 0.76
46 Glycomics: technologies taming a frontier omics field. OMICS 2010 0.76
47 Synthetic sugars enhance the functional glycomics toolkit. Nat Chem Biol 2006 0.75
48 Panels of chemically-modified heparin polysaccharides and natural heparan sulfate saccharides both exhibit differences in binding to Slit and Robo, as well as variation between protein binding and cellular activity. Mol Biosyst 2016 0.75
49 Heparin Isomeric Oligosaccharide Separation Using Volatile Salt Strong Anion Exchange Chromatography. Anal Chem 2016 0.75
50 Enrichment of Two Isomeric Heparin Oligosaccharides Exhibiting Different Affinities toward Monocyte Chemoattractant Protein-1. Anal Chem 2016 0.75